Researchers at the University of Maryland School of Medicine have engineered a novel protein therapy that acts as a first-ever antidote for carbon monoxide poisoning. By selectively and rapidly clearing carbon monoxide from the bloodstream, this treatment demonstrates a superior safety profile compared to existing approaches. The innovation promises to redefine emergency care protocols for carbon monoxide intoxication, which affects countless individuals worldwide with limited effective treatment options.